These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7577475)

  • 1. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
    Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
    Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
    van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
    Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
    Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
    Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
    Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D
    Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
    Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
    Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
    Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
    Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
    Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
    Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
    Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of BRCA2 gene in sporadic breast tumours.
    Bièche I; Noguès C; Lidereau R
    Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
    Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
    Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
    Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
    Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
    Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
    Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma.
    Katsama A; Sourvinos G; Zachos G; Spandidos DA
    Cancer Lett; 2000 Mar; 150(2):165-70. PubMed ID: 10704738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
    Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
    Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.
    Hanby AM; Kelsell DP; Potts HW; Gillett CE; Bishop DT; Spurr NK; Barnes DM
    Int J Cancer; 2000 Oct; 88(2):204-8. PubMed ID: 11004669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.